Genomic profiling reveals that metastasis specific genetic mutation or activation are enriched in PI3K/AKT signaling pathway in multiple types of cancer, including colorectal cancer [135, 146], melanoma [147, 148], prostate cancer [149], lung cancer, breast cancer, and renal cell carcinomas [150]. Here, AKT1 is linked to breast carcinoma.